Skip to main content

SUPERSTRING CAPITAL MANAGEMENT LP

Position in ZLAB — Zai Lab Ltd

CIK 1931118 NEW YORK, NY

Position in ZLAB

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$5,188,136
+$1,715,650 QoQ
Shares Held
275,818
+40.1% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
3.71%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZLAB Over Time

Shares Held

Position Value (USD)

Derivatives in ZLAB

reported options exposure · as of Sep 30, 2024
CallValue
$2,414,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUPERSTRING CAPITAL MANAGEMENT LP holds $130,439,416 across 32 Biotechnology names. ZLAB ranks #12 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ZLAB

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,188,136 275,818
2025-12-31 $3,472,486 196,853
2025-09-30 $6,799,282 200,628
2025-06-30 $4,717,278 134,895
2025-03-31 $10,659,384 294,947
2024-12-31 $10,571,069 403,630
2024-09-30 $15,134,138 626,932
2024-09-30 $2,414,000 100,000
2024-06-30 $3,729,034 215,178